Methyl prednisolone and lung function after cardiopulmonary bypass.
- 1 December 1979
- Vol. 34 (6) , 720-725
- https://doi.org/10.1136/thx.34.6.720
Abstract
Patients [31] undergoing cardiopulmonary bypass for elective aortic valve replacement were studied. The effects of some aspects of lung function of i.v. methyl prednisolone, administered immediately before bypass, were assessed by measuring alveolar-arterial O2 differences and shunt fractions. No significant differences in pulmonary function were found between the treated and control groups. The use of methyl prednisolone in this context is not justified.This publication has 8 references indexed in Scilit:
- Treatment or prevention of pulmonary cellular damage with pharmacologic doses of corticosteroid.1972
- Blood Damage in the Heart-Lung MachineExperimental Biology and Medicine, 1971
- Measurement of Pulmonary Edema in Valvular Heart DiseaseCirculation, 1967
- Nomograms for correction of blood Po2, Pco2, pH, and base excess for time and temperature.Journal of Applied Physiology, 1966
- Denaturation of plasma proteins as a cause of morbidity and death after intracardiac operations.1961
- The Postperfusion Pulmonary Congestion SyndromeAmerican Journal of Clinical Pathology, 1960